Discovery

Prostate cancer is the most common cancer in elderly men and the second most common cause of cancer-related death in men. It may be detected by digital rectal examination, but recently, researchers at the University of Michigan developed an experimental biomarker test that more accurately detects prostate cancer than any other screening method currently in use.

The study was published in a journal of the American Association for Cancer Research, mentioned that a simple urine test that screens for the presence of four different RNA molecules accurately identified 80 percent of patients in a study who were later found to have prostate cancer, and was 61 percent effective in ruling out disease in other study participants, far more accurate than the PSA blood test currently in use worldwide.

See the original report, here.